Ribociclib
CLEE011A2412B
Approved small_molecule active
Quick answer
Ribociclib for Metastatic Breast Cancer is a Approved program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Metastatic Breast Cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- active